Series B funding round for Colossal Biosciences raising $160M in January 2023
Series B funding round for Colossal Biosciences raising $160M in January 2023
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Sahil Lavingia |
| Angel | Jeff Bezos |
| Angel | Shervin Pishevar |
| Angel | Jeffrey Wilke |
| Angel | Sahin Boydas |
| Angel | Elia Montanari |
| Angel | Thomas Tull |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$615M
Top Valuation
-
Colossal Biosciences raised $160M in a Series B round.
The round was announced on 01/01/23.